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ABSTRACT
With the important role of the gut microbiome in health and disease, it is crucial to understand
key factors that establish the microbial community, including gut colonization during infancy. It
has been suggested that the first bacterial exposure is via a placental microbiome. However, des-
pite many publications, the robustness of the evidence for the placental microbiome and transfer
of bacteria from the placenta to the infant gut is unclear and hence the concept disputed.
Therefore, we conducted a systematic review of the evidence for the role of the placental, amni-
otic fluid and cord blood microbiome in healthy mothers in the colonization of the infant gut.
Most of the papers which were fully assessed considered placental tissue, but some studied
amniotic fluid or cord blood. Great variability in methodology was observed especially regarding
sample storage conditions, DNA/RNA extraction, and microbiome characterization. No study
clearly considered transfer of the normal placental microbiome to the infant gut. Moreover,
some studies in the review and others published subsequently reported little evidence for a pla-
cental microbiome in comparison to negative controls. In conclusion, current data are limited
and provide no conclusive evidence that there is a normal placental microbiome which has any
role in colonization of infant gut.
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Introduction
The conventional paradigm that the placenta is a sterile
organ has been challenged by a number of findings
indicating that it harbours a unique microbiome
(Aagaard et al. 2012; Stout et al. 2013; Aagaard et al.
2014; Vinturache et al. 2016). Recent studies have sug-
gested that these bacteria could influence reproductive
function and may affect pregnancy outcomes (Lauder
et al. 2016). Indeed, bacterial infection is a frequent
cause of neonatal sepsis and preterm birth (Goldenberg
et al. 2000).
Some published studies have presented evidence for
the presence of microbes in normal healthy placenta,
amniotic fluid, cord blood and meconium (Jimenez
et al. 2005; Collado et al. 2016; Parnell et al. 2017).
Several hypotheses have been suggested for potential
transfer of the bacteria from mother to infant in utero
(Doyle et al. 2017). Ascension from the vaginal tract
might be the most evident route of entry of the placen-
tal bacteria. However, alternative routes have also been
suggested, including bacteria derived from the mater-
nal intestine and oral cavity by translocation through
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the choriodecidual barriers as well as inclusion of a
uterine commensal microbiome into the developing
placenta. In utero colonization of the fetus/infant could
be hypothesized to affect immune function and meta-
bolic control after birth and potentially throughout life
(Neu 2016). Another intriguing issue is whether com-
mensal microbes are necessary for healthy placental
development and function, and if so, what the underly-
ing mechanisms are for these effects (Nuriel-Ohayon
et al. 2016). Consequently, placental bacteria may influ-
ence infant colonization and possibly long-term health
outcomes. It is already known that pathogenic microor-
ganisms colonizing the placenta can induce a pro-
inflammatory state, which may lead to abortion, pre-
term birth or potentially an increased risk of chronic
disease later in life. In a recent review of the mecha-
nisms for the increased risk of adverse pregnancy out-
comes in those with oral periodontal disease,
oral–utero transmission was considered a strong pos-
sible mechanism (Figuero et al. 2020).
In the early 1980s, Kovalovszki et al. (1982) were
the first to describe the presence of aerobic bacteria in
16% of tested placentas using a culture-dependent
approach without any histological evidence of cho-
rioamnionitis. Since then several additional reports
described the presence of bacteria in the human pla-
centa (Nuriel-Ohayon et al. 2016). Two studies using
culture-independent whole-genome shotgun sequenc-
ing of genomic DNA isolated from human placentas
support the existence of a placental microbiome in
healthy women. First, Aagaard et al. (2012) identified a
low abundance, but potentially metabolically rich
microbiome, including a number of commensal species
in both term and preterm placentas. Then Stout et al.
(2013) provided morphologic evidence that both gram-
positive and gram-negative bacteria of diverse mor-
phologies were present in a third of all placentas from
preterm and term pregnancies and Doyle et al. (2014)
using a 16S rDNA pyrosequencing approach identified
a distinct microbial community in placental membranes
from that reported by Aagaard et al. (2012). However
more recent studies have cast doubt on the existence
of a normal placental microbiome suggesting that con-
tamination around delivery, or during sample process-
ing and analysis may be a key factor in the detection of
bacteria in placental samples (Lauder et al. 2016;
de Goffau et al. 2019).
There are limited reports providing clear evidence
on where microbes might reside in the placenta. Stout
et al. (2013) reported that placental microbes were
intracellular, within the extravillous trophoblast (EVT)
cells in the maternal decidua, suggesting that the
endometrial epithelium of the non-pregnant uterus
might harbour occult microbes which could become
incorporated into the basal plate at the time of placen-
tal implantation. However, the impact of bacterial pres-
ence in the placenta and amniotic fluid needs to be
determined, good or bad. For example, does the type
of bacteria, the immune response they elicit or the abil-
ity of bacteria to reach critical numbers create the dif-
ference between normal and abnormal pregnancy
outcomes? Overgrowth of one or a few strains may be
harmful, while a diverse community of low numbers of
cells may not interfere with pregnancy (Stout et al.
2013). Another important unanswered question is
whether there is sufficient exposure of the fetus in utero
to affect the colonization of the infant gut. This could
be by direct colonization of the gut mucosa or by influ-
encing later interaction with mucosal cells or
immune cells.
The aim of the present study was therefore to sys-
tematically review and evaluate published studies
related to the placental, amniotic fluid and/or cord
blood microbiome in healthy women. We particularly
focussed on finding evidence for factors influencing the
colonization of the infant gut through placental trans-
fer. This is the first systematic review to look at this. We
assessed the quality of studies by considering potential
contamination during sample collection and processing
along with other key methodological considerations for
microbiota characterization and clear detail on mode of
delivery. Finally, we assessed how the “placental micro-
biome” may be important in normal full-term pregnan-
cies in contrast to preterm infants and infants with low
birthweight, or suffering from infection, neonatal sepsis
and other complications.
Methods
We conducted a systematic review to evaluate the evi-
dence for bacterial transfer between mothers and
infants via the placental route and if found, to assess
the relationship between early colonization of the
infant gut (prenatal and postnatal) and health out-
comes (brain development, metabolic disease, immune
system). Details of the literature review are available in
PROSPERO register CRD42017039875 and a flow chart
of the different steps is available in Figure 1.
The following criteria were applied for inclusion,
exclusion and critique of manuscripts:
 Detection of bacteria in mother needed to be
clearly described (amniotic fluid or placental tis-
sues) and the timing of the sampling mentioned.
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 Detection of bacteria in cord blood needed to
adhere to the same standards as for amniotic fluid
and placenta samples. In studies where it was
measured, infant faeces and sample collection tim-
ing including the frequency of sampling needed to
be clearly described (close to birth, e.g. first stool,
meconium or first sample after).
 Number of study mothers and infants should
be outlined.
 DNA extraction kit should be named, sample stor-
age conditions mentioned and, ideally, time
between storage and DNA extraction outlined.
 Information of the sequencing or PCR method
including the PCR kit, targeted genes, primers
sequences and sequencing details should be pro-
vided where relevant.
 Data on quality criteria and collection of samples
needed to be available: including methods used to
avoid contamination.
 Data around the “health-state” of the mother
should be provided (abnormal/normal health and/
or births, previous infections such as periodontitis
and gut diseases, pre-eclampsia, vaginal infections,
metabolic syndrome/GDM/obesity/weight data).
 Mode of delivery (caesarean or vaginal) must
be stated.
 Antibiotic use and other relevant medications such
as hypertension related medications should
be declared.
 Confirmation of maternal samples: e.g. placental,
vaginal, amniotic fluid, stool.
 Observational studies and controlled trials were
included, reviews were not.
Searches were carried out using PUBMED, OVID,
LILACS and PROQUEST. Further details regarding search
strings as well as inclusion and exclusion criteria are
available in PROSPERO register CRD42017039875.
Searches were carried out from the beginning of
records until June 1 2018. Reference lists of relevant
papers, including reviews, were searched for additional
studies for consideration.
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Figure 1. Prisma Flow diagram.
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Titles and abstracts of the studies identified by the
search were screened by four independent assessors
(CAE, AG, RR, CvLB) and discrepancies between deci-
sions were presented and discussed with the whole
group for final agreement. Full text reports of all
included studies were assessed, data on sample collec-
tion (method, timing, contamination risk assessment,
frequency, number of samples), long-term persistence
of bacteria in infant tissues and faecal samples, sample
handling after collection (DNA extraction kit name, time
between storage and DNA extractions, storage condi-
tions), study sample size (number of samples and study
participants), sample analysis (main identification meth-
ods and statistics), maternal confounders (mode of
delivery, birth conditions, maternal health profile) and
other confounders (antibiotic use, other medications,
mode of delivery) were collected.
Based on the information collected a quasi-risk of
bias analysis was conducted as the traditional risk of
bias analysis was not feasible for a systematic review of
this kind. Paper quality was scored as high, medium, or
low with all low graded papers rejected. The experts
(CAE, AG, RR, CvLB) then discussed a final list of papers
for inclusion into the systematic review results
(Supplementary Table S1).
Results
Of 2657 non-duplicate papers found in the search on
June 1 2018, 48 were assessed for eligibility at the full
text screening stage (Figure 1). Finally, 19 papers were
included in the qualitative synthesis of which eight con-
centrated on normal term pregnancies (Table 1). The
other eleven papers compared premature delivery, low
birth weight or pre-eclampsia to normal term birth
(Table 2).
The synthesized publications included data on pla-
cental, amniotic and/or cord blood microbiomes with
between two and 168 samples each. The approaches
used to avoid contamination of the placenta during
sample collection varied in the details presented which
were sometimes vague, especially in studies that
included vaginal births where risk of contamination is
high (Tables 1 and 2). Some studies considered only
elective caesarean delivery (Collado et al. 2016) and/or
only the placental structures that were not exposed to
external contamination in utero (Lauder et al. 2016). A
range of methods were used in the studies to identify
bacteria including various staining approaches, PCR and
metagenomics tools (Tables 1 and 2). Storage condi-
tions of samples varied from 20 to 80 C and the
storage time of the DNA sample was usually not
reported. There is differential deterioration of DNA
between species of bacteria over time, so the storage
time before DNA extraction is important and should be
the same for all samples in a study. Methods used to
extract DNA/RNA varied and were not always reported
in detail. Some studies used a bead beating step (Lim
et al. 2018), others used lysozyme incubation, and dif-
ferent extraction kits were used (Tables 1 and 2). The
use of different extraction kits will likely lead to differ-
ent results in terms of amount and quality of DNA isola-
tion (Hart et al. 2015). In addition, different variable (V)
regions of the 16S rRNA gene were targeted, for
example either V4 or V6. Only one study looked at
V1–V9 (Parnell et al. 2017), but then concentrated on
V4. This makes direct comparisons of populations of
bacteria in the microbiome between studies difficult.
Negative controls were used in a few recent studies
(Lauder et al. 2016; Parnell et al. 2017; Rehbinder et al.
2018) but not in earlier studies.
Not all samples from normal term pregnancies con-
tained bacteria (Lauder et al. 2016; Amarasekara et al.
2015), whereas a randomized controlled trial with pro-
biotics by Rautava et al. (2012) reported DNA from lac-
tobacilli and bifidobacteria in all placentas studied. In
other studies, the bacteria isolated in the placenta were
identified to be of an oral type (Aagaard et al. 2014).
Very few studies considered possible bacteria transfer
to the infant (to meconium or infant faeces) and overall,
there was no substantial evidence for or against the
role of a placental microbiome in the colonization of
the infant gut in meconium or infant faeces.
Normal pregnancies
Placenta and amniotic fluid
Satokari et al. (2009; Table 1) analysed placenta samples
from vaginal and caesarean deliveries, all full term, for
the presence of Bifidobacterium and Lactobacillus spe-
cies. Bacterial DNA was extracted directly from placenta
samples and resected placenta homogenized tissue
samples were cultured under anaerobic conditions
using a non-selective medium. Selected colonies were
subjected to 16S rDNA sequencing for species identifi-
cation. DNA from bifidobacteria and/or L rhamnosus
were found in most but not all placenta (Table 1) but
bifidobacteria or lactobacilli were not found by cultiva-
tion and any bacterial species which were cultured
from placenta samples were suspected to be due to
contamination during delivery.
Collado et al. (2016; Table 1) collected samples from
several maternal sites (placenta, amniotic fluid, colos-
trum, and faeces). They compared these with paired
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infant meconium and faeces. These mothers were part
of a probiotic intervention study. Deliveries were full
term and by elective caesarean and careful and sterile
processing procedures were used to avoid contamin-
ation of the samples (Table 1). However, negative con-
trols for DNA extraction were not reported. Mothers
with conditions that might affect placental and fetal
physiology (e.g. pre-eclampsia, intrauterine growth
retardation, fetal anomalies, onset of labour, asphyxia)
or contaminate the placenta (rupture of membranes,
vaginal delivery, infection) were excluded from the
study. Bacteria were cultured and the microbiome
assessed by 16S rRNA gene pyrosequencing, quantita-
tive PCR, and denaturing gradient gel electrophoresis.
The authors reported a distinct microbiota in placenta
and amniotic fluid samples that was of low diversity
and richness dominated by Proteobacteria especially
Enterobacteriaceae. Enterobacter and Escherichia/
Shigella. Lower abundances of these were also found in
colostrum, meconium and infant faeces.
Propionibacterium was also detected in placenta and
amniotic fluid as well as in meconium and infant faeces.
Over half the family level bacterial phylotypes found in
meconium were identified in amniotic fluid and pla-
centa or just in amniotic fluid.
Parnell et al. (2017; Table 1) suggested a niche-speci-
ficity to the placental microbiota, and that placental
microbiome studies should consider regional differen-
ces in colonization which may affect maternal, fetal,
and/or neonatal health and physiology. This study
included at term pregnancies from 57 women with
both singleton and twin births. Genomic DNA sequenc-
ing of multiple variable regions of the bacterial 16S
ribosomal gene explored the microbial profiles from
the basal plate (BP), which is in direct contact with
maternal uterine, endothelial, and immune cells; pla-
cental villi (PV), which are bathed in maternal blood;
and fetal membranes (FM), which encapsulate the
amniotic cavity. Sterile techniques were used in sam-
pling the placenta to avoid contamination. Human DNA
was removed and negative controls were run for DNA
at all stages with real time PCR was used to confirm
results. The authors looked at all V1–V9 variable
regions, but finally concentrated on V4. They identified
most common OTUs and then species. The abundance
and diversity of microbes differed by sampling location
in the placenta. There were higher copy numbers in the
BP and PV than the FM which also had lower diversity.
BP was dominated by Proteobacteria, FM by Firmicutes
and PV had no consistent pattern. Ralstonia insidiosa
from the Burkholderiales order, (which has also been
found in breastmilk) was found in 76% of validated BPTa
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samples. Finally, microbial profiles were not altered by
mode of delivery (Parnell et al. 2017).
The control group from a study (Tuominen et al.
2018; Table 1), designed to investigate the impact of
existing human papillomavirus (HPV) infection on the
placental microbiota was considered in this review. The
microbiome was characterized by 16S rRNA gene
sequencing. A total of 19/39 placenta samples (49%)
were included in the analysis after exclusion of speci-
mens with a low number of reads followed by filtering
the OTUs present in the negative controls. For HPV
negative samples (control group), the most abundant
phylum in the placenta was Firmicutes (58.3%) followed
by Proteobacteria (21.1%), Actinobacteria (13.8%) and
Bacteroidetes (6.5%). At family level, Staphylococcaceae
(22.5%), Enterococacceae (15.6%), Veillonellaceae
(8.8%), Corynebacteriaceae (6.3%) and Moraxellaceae
(6.1%) were the predominant groups. At genus level,
Staphylococcus (22.9%); unclassified Enterococcaceae
genus (15.6%), Corynebacterium (6.3%), and
Acinetobacter (6.0%) were the most abundant.
Even though the previous studies suggested the
presence of a commensal microbiota in the placenta
and amniotic fluid, other studies have questioned this
hypothesis. Rehbinder et al. (2018; Table 1) investigated
the presence of a microbiota in sterilely collected amni-
otic fluid in uncomplicated pregnancies at term in the
Preventing Atopic Dermatitis and Allergies in children
(PreventADALL) study cohort. Amniotic fluid was ran-
domly sampled at caesarean delivery from 65 pregnan-
cies at term. Ten elective (planned, without on-going
labour) caesarean deliveries with intact amniotic mem-
branes were selected, while 14 with prior rupture of
membranes were included as controls. Amniotic fluid
was analysed by culture-independent and culture-
dependent techniques. The median concentration of
prokaryotic DNA was low for the group with intact
membranes, while the group with rupture of amniotic
membranes had >10-fold higher levels. Also, bacteria
were detected in 50% of the ruptured amniotic mem-
branes samples by anaerobic culturing, while none of
the intact membranes samples showed bacterial
growth. Sanger sequencing of the ruptured amniotic
membrane samples identified bacterial species that are
commonly part of the vaginal microbiota and/or associ-
ated with intrauterine infections. The authors con-
cluded that fetal development in uncomplicated
pregnancies occurs in the absence of an amniotic fluid
microbiota and that the offspring microbial colonization
starts after uterine contractions and rupture of amni-
otic membrane.
Another recent study (Lim et al. 2018; Table 1) con-
cluded that amniotic fluid from healthy term pregnan-
cies did not harbour a detectable microbial community.
In this study, the virome and bacterial microbiota of
amniotic fluid from 24 uncomplicated term pregnancies
were characterized using next-generation sequencing
methods. They did not identify a population of bacterial
microbiota in the amniotic fluid from healthy term
pregnancies that meaningfully differed in concentration
or content from the sequences amplified from negative
controls. Similarly, they found only limited evidence for
viral presence using metagenomic sequencing of
material that was subjected to preparation techniques
optimized to recover DNA as well as RNA viruses,
including DNA and RNA bacteriophages.
Lauder et al. (2016; Table 1) compared placental
samples from 6 healthy deliveries to a matched set of
contamination controls, as well as to oral and vaginal
samples from the same women and quantified total
16S rRNA gene copies by quantitative PCR; equal vol-
umes of the purified DNA of all samples were used in
the assay. DNA was purified with two different kits. All
placental and negative control samples were at the
extreme low end of the range detectable by qPCR (a
highly sensitive methodology). For both purification
methods, the authors concluded that placental and
control samples showed low and indistinguishable
numbers of 16S rRNA gene copies. Thus, due to the low
amounts of bacteria detected in placenta, some or all
the bacterial DNA may come from contamination by
dust or commercial reagents. These findings highlight
the importance of negative controls which were gener-
ally not included in most other studies.
One study (Jimenez et al. 2015; Table 1) isolated
commensal bacteria from umbilical cord blood of 20
healthy neonates born by caesarean section. The blood
samples were submitted to an enrichment step and
then inoculated onto agar plates. Bacterial isolates were
identified using PCR and 16S rDNA sequencing; they
belonged to the genus Enterococcus, Streptococcus,
Staphylococcus, or Propionibacterium.
Complicated pregnancies
To understand the potential existence and role of the
placenta microbiome in normal pregnancy, it is useful
to compare the data with that from abnormal pregnan-
cies. A subset of the studies specifically addressed com-
parison between abnormal and a normal healthy
control group.
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Pre-eclampsia
Amarasekara et al. (2015; Table 2) confirmed the pres-
ence of bacteria (including Bacillus cereus, Listeria,
Salmonella, Escherichia; Klebsiella pneumonia,
Anoxybacillus, Variovorax, Prevotella, Porphyromonas,
and Dialister). in 12.7% of placental tissues
collected during caesarean delivery of 55 women with
pre-eclampsia but not those of 55 matched controls
using next generation sequencing (Illumina MiSeq). A
small piece of placental tissue was immediately dis-
sected from a cotyledon close to the insertion of the
umbilical cord. Stringent aseptic measures were fol-
lowed throughout the collection and analysis of the
sample to prevent contamination.
Gestational diabetes
Bassols et al. (2016) investigated the placental micro-
biome in women with gestational diabetes (Table 2).
The study population consisted of 22 Caucasian women
(11 with gestational diabetes mellitus (GDM) and 11
control non-GDM women with normal pregnancies). All
infants were born at term. The placentas were collected
after childbirth in the delivery room or operating room
to ensure sterility and samples were collected from the
inner surface of the placenta to avoid the placenta
being contaminated by the vagina. The samples were
then stored within 1 h at 80 C until DNA and
RNA extraction.
They found a distinct pattern of placental microbiota
in GDM compared with controls. The diversity of pla-
cental microbiota was mainly related to four phyla:
Proteobacteria, Bacteroidetes, Firmicutes, and
Actinobacteria in GDM. The proportion of Firmicutes
was 7% higher and the proportion of Proteobacteria
and Bacteroides were respectively reduced at 5 and 2%
lower in GDM compared to levels in control women. A
lower relative abundance of Acinetobacter was associ-
ated with increased glucose plasma levels, lower blood
eosinophil count in the second and third trimester of
pregnancy and lower placental expression of the anti-
inflammatory cytokines IL10 and TIMP3. Furthermore, a
lower relative abundance of Pseudomonadales was
associated with lower blood neutrophil and lymphocyte
counts in the second and third trimester of pregnancy
and with lower placental expression of IL10, ITGAX, and
MRC1MR (Bassols et al. 2016).
Preterm birth
DiGiulio et al. (2008; Table 2) reported microbial DNA in
the amniotic cavity from women in preterm labour tak-
ing part in a retrospective cohort study (53 infants
delivered at term and 113 preterm). Microbial genomic
DNA was extracted from the amniotic fluid sample col-
lected during amniocentesis and analysed by real time
PCR. Microbial invasion of the amniotic cavity, defined
by either a positive end-point PCR or culture of amni-
otic fluid, was found in only 15% (25/166) of patients.
Seventeen bacterial species (belonging to five phyla)
and 1 fungal species were identified. Six of the 17 bac-
teria taxa were detected by culture and PCR and others
only by culture (4 taxa) or PCR only (7 taxa) (Table 2).
The prevalence of a positive amniotic fluid was
inversely related to gestational age at delivery.
Jones et al. (2009; Table 2) investigated the preva-
lence and diversity of bacterial species in placental
membranes of mothers suffering intrauterine infection
compared with healthy mothers. They isolated bacterial
DNA from fetal membranes and placenta using 16S
rDNA and PCR cloning and sequencing and identified
particular species, namely U. parvum, U. urealyticum, M.
hominis, Fusobacterium spp. and S. agalactiae using
qPCR. Of 74 women recruited, 26 (11 caesarean) exhib-
ited prolonged rupture of membranes and delivered
preterm infants <32weeks gestational age; 19 (all vagi-
nal birth) delivered preterm infants <32weeks due to
spontaneous labour; 8 with indicated preterm delivery
<32weeks; and 21 delivered term infants (11 caesar-
ean). Twenty two (30%) women had bacterial DNA
detected in fetal membranes and placental tissue.
Thirty-two (43%) women were positive for bacterial
DNA by species specific rtPCR, but only 14 of these
women were positive using both methods. 50% (5/10)
of term vaginal deliveries were positive for bacterial
DNA. However, little spread was observed through tis-
sues and species diversity was restricted. Only low lev-
els of bacteria were detected in term elective section or
indicated preterm deliveries. Bacterial prevalence was
significantly increased in samples from spontaneous
preterm labour with intact membranes (89% versus
50% in term vaginal delivery) and prolonged rupture of
membranes with caesarean section (55% versus 0% in
term elective caesarean section). Moreover, bacterial
spread and diversity was greater in the preterm groups
versus term vaginal deliveries. A positive PCR result was
associated with histological chorioamnionitis in pre-
term deliveries.
Aagaard et al. (2014; Table 2) investigated a popula-
tion-based cohort of placental specimens collected
under sterile conditions from 48 subjects with extensive
clinical data for comparative 16S ribosomal DNA–based
and whole-genome shotgun (WGS) metagenomic stud-
ies. Placental specimens were passed immediately to
trained personnel in a sterile clean container. Identified
taxa and gene carriage patterns were compared to
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other human body site niches, including oral, skin, air-
way (nasal), vaginal, and gut microbiomes from non-
pregnant controls. A unique placental microbiome
niche was identified, composed of non-pathogenic
commensal microbiota from the Firmicutes,
Tenericutes, Proteobacteria, Bacteroidetes, and
Fusobacteria phyla. In aggregate, the placental micro-
biome profiles were most akin (Bray-Curtis dissimilarity
<0.3) to the human oral microbiome. 16S-based oper-
ational taxonomic unit analyses revealed associations of
the placental microbiome with a remote history of
antenatal infection.
In a short communication Doyle et al. (2014; Table 2)
reported the analysis of bacteria DNA from placental
membranes (chorion and amnion) of 14 mothers who
gave birth preterm by spontaneous vaginal delivery
(intake membranes at 8–32weeks) all with chorioam-
nionitis and compared them with term births by caesar-
ean (4 non-labouring mothers after 37weeks with
intact membranes) vaginal birth (6 mothers). Bacterial
DNA was extracted and amplified by PCR, followed by
pyrosequencing. There were many similarities between
term deliveries but more lactobacilli in vaginal vs cae-
sarean deliveries. There were more Fusobacterium,
Streptococcus, Mycoplasma, Aerococcus, Gardnerella,
Ureaplasma and Enterobacteriaceae in pre-
term placentas.
Antony et al. (2015; Table 2) showed that excess ges-
tational weight gain (GWG) was associated with signifi-
cant alterations in the composition of the placental
microbiome and its bacterially encoded metabolic path-
ways, suggesting that the mechanism by which excess
GWG results in preterm birth may be through aberra-
tions in the placental microbiome. In this study, 320
placentas were collected from term and preterm preg-
nancies and sections taken from different areas of the
placenta with very good procedures to reduce of con-
tamination risk during sampling. The patterns of the
RNA metagenomics were clustered by excess GWG and
when the phyla level relative taxonomic abundance of
mothers delivered preterm was compared by maternal
weight gain, the authors reported increased abundance
of Firmicutes, Actinobacteria, and Cyanobacteria and
decreased relative abundance of Proteobacteria. This
was also seen at family and genus level (Vibrio,
Burkholderia, and Beijerinckia).
Prince et al. (2016; Table 2) found that the placental
microbiome was altered among subjects with spontan-
eous preterm birth (delivered 32–36weeks) with and
without chorioamnionitis in a cross-sectional analysis
with six nested spontaneous birth cohorts. Each cohort
had 9 to 15 subjects (term gestations without
chorioamnionitis, term with chorioamnionitis, preterm
without chorioamnionitis, preterm with mild chorioam-
nionitis, preterm with severe chorioamnionitis, and pre-
term with chorioamnionitis and funisitis). Preterm
subjects with chorioamnionitis had fewer bacterial con-
stituents of their placental membrane microbiome and
those with severe chorioamnionitis had high abundan-
ces of Ureaplasma parvum, Fusobacterium nucleatum,
and Streptococcus agalactiae.
Doyle et al. (2017; Table 2) aimed to describe the
microbiota found in placental tissue and fetal mem-
branes (chorion and amnion) from a cohort of women
in rural southern Malawi. They examined the microbial
community structure and explored if this differed in
placental tissue exhibiting chorioamnionitis.
Participants (n¼ 1391) were enrolled prospectively into
the main trial before 20weeks gestation and followed
throughout pregnancy, childbirth and beyond. Those
with severe chorioamnionitis delivered on average 0.4
gestational weeks earlier and had a lower observed
number of OTUs in the placenta and fetal membranes.
A significantly higher mean bacterial load of
Mycoplasmataceae, Leptotrichiaceae and Veillonaceae
was observed in placental tissues with severe chorioam-
nionitis. Fusobacterium nucleatum, Ureaplasma sp. and
Gemella asaccharolytica were associated with a shorter
duration of pregnancy.
Low birth weight
Zheng et al. (2015; Table 2) demonstrated that placen-
tal microbiome also varied in association with low birth
weight in a study of 12 low birth weight and 12 normal
birth weight full-term neonates (gestational age 37w
0d–41w 6d). Placental samples were collected and
immediately passed to trained personnel in a sterile
clean container. The bacteria in placental tissues were
characterized by 16S ribosomal DNA amplicon high-
throughput sequencing. Low birthweight infants had
lower diversity, less lactobacillus, lower relative abun-
dance of Firmicutes but more Proteobacteria and
Actinobacteria than normal birth weight infants. They
also had a lower abundance of Enterococcus but more
Lactococcus and Bacillus (Table 2).
In the study of Doyle et al. (2017), carried out in a
cohort of 1391 women in rural Malawi (see Preterm
Birth section above), higher placental and vagina loads
of Sneathia sanguinegens, Prevotella copri,
Lachnospiraceae sp. and Phascolarctobacterium succina-
tutens were significantly associated with lower length
for age z score in newborns.
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Neonatal sepsis
Amniotic fluid and cord blood (Table 2) were evaluated
in a study of preterm births with intra amniotic infec-
tion (IAI) and/or early-onset neonatal sepsis (AEONS),
Wang et al. (2013; Table 2). PTB cases were grouped as
1) Group 1– neonatal blood culture-positive AEONS
(n¼ 6); 2) Group 2– neonatal blood culture-negative
presumed AEONS with positive IAI (n¼ 16); 3) Group 3–
neonatal blood culture-negative presumed AEONS with
no IAI (n¼ 7); or 4) Group 4– no AEONS or IAI (n¼ 7).
Samples from healthy term deliveries (n¼ 8) served as
technical controls. Eighteen species (7 non redundant)
were identified by 16SrRNA sequencing in cord blood
in comparison to 31 (15 non redundant) in amniotic
fluid. Few of these species were cultured. Many of the
species found in cord blood were also found in the
amniotic fluid of the same mother/infants. E. coli and F.
nucleatum were the most common.
Intervention studies – transfer of bacteria from
mother to infant
There were no studies that directly considered transfer
of normal placental microbiome to the infant.
Discussion
In this systematic review, the key aim was to determine
if there was evidence for a placental, amniotic fluid
and/or cord blood microbiome in normal full-term
births and whether this was transferred to the infant,
influencing colonization of the infant gut. A further aim
was then to establish if such microbiomes were present
in and/or modulated in complicated pregnancies. Our
findings reveal no evidence for any transfer of bacteria
from the placenta to the infant in healthy pregnancies
and conflicting evidence for the presence and role of
the placental microbiome due to lack of consistency in
methodology and in particular to weaknesses in pre-
vention of contamination during sample collection,
processing, storage and analysis.
Early histological studies visualized bacteria on the
placenta. Stout et al. (2013) identified intracellular bac-
teria in the basal plate for 195 placentas collected
12 h from delivery in term and preterm gestations
using histochemical analyses. Gram-positive and Gram-
negative intracellular bacteria of diverse morphologies
were documented in the basal plates of 27% of all pla-
centas. However, no attempt was made to use bacterial
isolation and identification by molecular techniques.
Two major observational studies of healthy pregnan-
cies included in our review supported the presence of
commensal bacteria in the placenta (Aagaard et al.
2014,Collado et al. 2016). In addition to the studies in
the systematic review, a probiotic intervention study by
Rautava et al. (2012) evaluated whether microbes in
placenta or amniotic fluid can affect fetal innate
immune gene expression during late pregnancy and
whether innate immune gene expression profiles in the
placenta and fetal gut can be modulated by dietary
supplementation with probiotics. They did not look at
infant faecal bacteria. Forty three pregnant women
were randomized to receive Bifidobacterium lactis, B.
lactis in combination with Lactobacillus rhamnosus GG
(LGG) or placebo for 14 days before elective caesarean
section at full term in a double-blind clinical trial. Only
29 mother-infant pairs completed the study. Bacteria in
placenta were detected by quantitative (q)PCR and bac-
terial DNA for lactobacilli was detected in all placenta
samples with DNA from bifidobacterium, bacteroides
and Clostridia leptum groups in many but not all sam-
ples. Lactobacilli and bifidobacterium group DNA were
also found in some, but not all, amniotic fluid samples.
This was associated with changes in fetal intestinal
innate immune function related gene expres-
sion profile.
These studies in humans contradicted the dogma
that the fetus resides in a sterile environment, propos-
ing the presence of microbes in the fetal maternal unit,
which includes the placenta, amniotic fluid, cord blood
and meconium. The concept of a maternal-fetal-micro-
bial triad comprising a “holobiont,” that is highly inter-
dependent has been proposed (Neu 2016). When the
commensal microbiota is perturbed, an inflammatory
response to altered intrauterine microbial communities
has been linked to preterm delivery, as well as to
increased risk for several brain, lung, and eye diseases
in these infants (Neu 2016). In contrast, more recent
studies contradict this in utero colonization hypothesis
concluding that placenta and amniotic fluid from nor-
mal healthy pregnancies are free of bacteria (de Goffau
et al. 2019; Lim et al. 2018; Rehbinder et al. 2018; Leiby
et al. 2018; Perez-Munoz et al. 2017).
In challenged births (including preterm), there is
more evidence for a placental microbiome and differen-
ces between normal and compromised births. This may
be due to the higher levels of pathogenic bacteria
which are more easily detected than a potential com-
mensal microbiota (Tables 1 and 2). However, there
were still many issues related to possible contamination
of samples during collection, processing and DNA
extraction that make interpretation of the data difficult.
Adding to this are variations in both the reporting of
and the actual DNA extraction methodology including
the different regions of the rRNA gene studied which
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could influence the results. These confounding factors
make it very difficult to compare studies, confirm obser-
vations and draw overall conclusions. The scarce results
obtained with the placental microbiota and microbiome
from women with GDM show that they differ from con-
trol women with lower levels of Pseudomonadales
order and Acinetobacter genus, the lower abundance of
placental Acinetobacter being associated to a more
adverse metabolic and inflammatory phenotype
(Bassols et al. 2016). Inflammation is a key part of the
parturition process and external factors including infec-
tion or chronic low grade inflammation can increase
the risk of premature labour (Behnia et al. 2016; Menon
et al. 2019). A commensal placental microbiota in a
non-healthy pregnancy could theoretically have a mod-
ulatory effect on the immune system, leading to a local
anti-inflammatory environment, contributing to sys-
temic protection from the GDM, but evidence for this
is lacking.
Potential sites of origin of the maternal-fetal micro-
biome include the vagina as most the probable location
via ascension and translocation through the choriode-
cidual barriers. However, alternatives suggested include
hematogenously derived sources such as maternal peri-
odontitis and the maternal intestinal tract due to higher
intercellular junctional permeability and/or dendritic
cell transport (Neu 2016). Several papers have sug-
gested a uterine commensal microbiome when not
pregnant and some of these could be incorporated into
the developing placenta (Baker et al. 2018; Benner
et al. 2018).
It has been proposed by Wassenaar and Panigrahi
(33) that there are three elements that determine
whether the outcome of bacterial presence in the pla-
centa and amniotic fluid is good or bad (Wassenaar and
Panigrahi 2014). First, which bacteria are present and
whether they can be eliminated or reduced by the
immune system, Second, whether the resultant immune
response itself becomes detrimental and lastly if the
bacteria can survive and achieve pathological popula-
tion levels.
Overgrowth of one or a few strains seems to be
harmful, while a diverse community of low numbers
of cells, do not seem to interfere with pregnancy.
Consequently, the placenta may function as an active
low biomass ecologic niche that harbours a unique
microbiome, which could be hypothesized to protect
against harmful microbial dominance. However, these
low levels of colonization still need to be robustly
confirmed, but if this happens, these observations
challenge not only the assumed notions of “from
when and where” our earliest microbes colonize (or
are seeded), but also the concepts of inflammatory
mediators, reproductive immunity, and whether
microbes in such niches constitute more friend than
foe (Prince et al. 2016). This process of colonization
may influence health and disease not only early in
life but in some cases throughout life. In fact, in utero
colonization, if it occurs, could have major impact on
the developing mammalian host in terms of develop-
ment of immunity and metabolism that, with epigen-
etic modifications, may link to disease risk later in life
(Neu 2016). As an example, gestational diabetes, a
clinical situation that clearly influences pregnancy
outcomes not only for the mother but also for the
infant, has been recently associated with changes in
placental microbiota, suggesting that placental micro-
biota may be a new target for therapy in for instance
gestational diabetes (Bassols et al. 2016).
A challenge in working with specimens with low
bacterial biomass, such as placental samples, is that
some or all of the bacterial DNA may derive from con-
tamination. In fact, Lauder et al. (2016), quantified total
16S rRNA gene copies using quantitative PCR and two
different DNA purification methods, and found that pla-
cental samples and negative controls contained low
and indistinguishable copy numbers. Consequently,
studies need to be designed and executed using rigor-
ous quality standards and state-of-the-science metage-
nomics evaluating potential contamination. This is
especially true with samples in which the placenta is
collected after vaginal delivery and therefore prone to
contamination from the birth canal (Nuriel-Ohayon
et al. 2016).
A very recent study examined the potential micro-
biome in 537 pregnancies where infants with compli-
cated and uncomplicated pregnancy were born by pre-
labour Caesarean section (de Goffau et al. 2019). They
used negative and positive controls and considered
batch effects in the metagenomic and 16S rRNA
sequencing data. They also controlled for mode of
delivery and considered the possible origin of any bac-
teria detected to rule out vaginal contamination. The
authors concluded that there was no evidence for a pla-
cental microbiome and most bacteria detected were
contaminants during sample collection or from kits and
reagents in both normal and complicated pregnancies.
The only exception was the potential pathogen
Streptoccocus agalactiae found in 5% of samples col-
lected before labour started.
In conclusion, our study has shown that there is
great variability in the detection of bacteria in the pla-
centa of normal term births with little data available
from the cord blood microbiome. Where a placenta
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microbiome is reported, there is a large variation in the
type and diversity of bacteria found in different studies.
This could indicate potential site specificity but also
that different methodologies were used for extraction
and analysis of the microbial DNA, and it is most likely
that contamination had a major impact on the results.
The pathological birth studies clearly differed compared
to the normal birth studies, but even these may have
detected potential contaminants rather than a
true microbiome.
Our findings highlight the need for studies with
improved quality and reproducibility of the methodolo-
gies and, in particular, avoidance of the risk of contam-
ination. Overall, more studies carried out in a
harmonized way are needed to ensure solid evidence
for bacterial transfer from the mother to the infant.
Specifically, future research approaches need to be
more consistent with DNA extraction both in terms of
timing and methods. Methods need to be harmonized
to avoid contamination and agreement should be
reached on which regions of the rRNA gene should be
examined. Lastly, future experiments should focus on
larger birth cohorts of normal birth mothers with a
study set up that enables tracking of the bacteria to the
gut of infants. Thus, the results from this systematic
review support the notion that a placental microbiome
may not be a normal phenomenon and may indeed be
the result of contamination. There is no evidence that it
plays a role in early gut microbial colonization of
the infant.
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